Nurix Therapeutics, Inc. NRIX License revenue — Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s license revenue — revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s license revenue — revenue?
- Nurix Therapeutics, Inc. (NRIX) reported license revenue — revenue of $30M in Q4 2025.
- What does license revenue — revenue mean?
- This metric represents revenue generated from licensing intellectual property, technology platforms, or drug candidates to third-party partners. It reflects the company's ability to monetize its research and development pipeline through strategic collaborations and milestone payments. This revenue stream is a key indicator of the commercial validation of the company's proprietary drug discovery platform.